Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,783 | 71,847 | 76,416 | 88,740 | 122,754 |
| Marketable Securities | 7,035 | 15,554 | 23,649 | 18,185 | 19,024 |
| Receivables | 14,029 | 5,380 | 60,129 | 40,401 | 21,793 |
| Other current assets | 0 | 0 | -1 | 0 | 0 |
| TOTAL | $52,848 | $92,781 | $160,193 | $147,326 | $163,571 |
| Non-Current Assets | |||||
| PPE Net | 4,928 | 5,554 | 6,842 | 9,000 | 12,037 |
| Investments And Advances | 11,829 | 11,125 | 10,602 | 37,001 | 47,180 |
| Intangibles | 0 | 0 | 450 | 1,639 | 52,284 |
| Other Non-Current Assets | 1,355 | 10,716 | 21,264 | 24,039 | 41,405 |
| TOTAL | $18,113 | $27,396 | $39,159 | $71,680 | $152,905 |
| Total Assets | $70,960 | $120,177 | $199,352 | $219,005 | $316,475 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,959 | 9,424 | 9,671 | 2,215 | 36,378 |
| Accounts payable and accrued liabilities | 17,019 | 17,321 | 18,419 | 22,032 | 33,805 |
| Other current liabilities | 11,291 | 8,278 | 8,461 | 12,396 | 9,542 |
| TOTAL | $41,465 | $35,690 | $42,899 | $43,554 | $94,513 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,581 | 24,116 | 33,505 | 42,301 | 15,975 |
| Deferred Revenues | 3,196 | 667 | 6,348 | 6,912 | 14,789 |
| Other Non-Current Liabilities | 38,471 | 47,755 | 52,030 | 58,723 | 42,858 |
| TOTAL | $54,052 | $74,928 | $100,281 | $118,397 | $94,848 |
| Total Liabilities | $95,516 | $110,618 | $143,180 | $161,951 | $189,361 |
| Shareholders' Equity | |||||
| Common Shares | 5,303 | 4,536 | 4,377 | 4,226 | 4,706 |
| Retained earnings | -492,772 | -418,085 | -364,619 | -348,021 | -322,055 |
| Other shareholders' equity | 1,265 | 29 | 536 | 863 | 538 |
| TOTAL | $-24,556 | $9,559 | $56,173 | $57,054 | $127,112 |
| Total Liabilities And Equity | $70,960 | $120,177 | $199,352 | $219,005 | $316,473 |